What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma
(technologyreview.com)
1.
2.
BioNTech Shares Fall After Co-Founders Plan Exit and Outlook Misses Forecasts
(feeds.content.dowjones.io)